THE PREDICTION AND ASSESSMENT OF CARDIOVASCULAR AND RENAL DISEASE IN TYPE 2 DIABETES. A CURRENT REVIEW

Abstract

According to the current guidelines all type 2 diabetes (T2DM) subjects are at high cardiovascular (CV) risk. Scientists are researching the issue of further risk stratification among already high-risk patients, improved cost-effective risk stratification tools being under development. The assessment of the CV risk with the help of prediction models developed for the general population is considered to be not accurately enough for high risk individuals, therefore the current interest for identifying novel biomarkers and the development of specifically designed risk-scores for individuals with diabetes.